← Leaderboards
Mohammad Haroon Asif Choudry
University Of Pittsburgh At Pittsburgh
$1,176,755
Attributed
$1,176,755
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.5K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,176,755 · 3
By mechanism
R21$1,176,755 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Richard D Wood$10,078,142
- Bruce A Mc Clane$13,048,720
- Francisco A Uzal$1,415,271
- Jihong Li$859,097
- James M Pipas$12,785,501
Others in their field
Other Emerging Leaders on “Preclinical Study”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$43,147,107
- John Damon Chodera · Sloan-Kettering Inst Can Research$35,457,751
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
Research focus
Preclinical StudyPolymersMucinousOrganoidsInstitutionPharmaceutical PreparationsInternationalIn Vivo ModelNeoplasm MetastasisMucous Body SubstanceExtracellularBromelainsCancer CellPeritonealAcetylcysteineColorectal CancerIntraperitonealIn VitroMucinous NeoplasmDoseMucolyticsChemotherapyBiomedical Referral Center3-Dimensional
Grant awards (6)
Application of mucus modulating multipurpose trypsin nanoparticles to overcome the mucus barrier and deliver mitochondria-targeted anticancer drugs in mucinous carcinoma peritonei$218,538
R21 · FY2023 · CA · contact PI
Application of mucus modulating multipurpose bromelain nanoparticles to overcome the mucus barrier in appendiceal pseudomyxoma peritonei$216,626
R21 · FY2022 · CA · contact PI
Application of mucus modulating multipurpose trypsin nanoparticles to overcome the mucus barrier and deliver mitochondria-targeted anticancer drugs in mucinous carcinoma peritonei$185,831
R21 · FY2022 · CA · contact PI
Application of mucus modulating multipurpose bromelain nanoparticles to overcome the mucus barrier in appendiceal pseudomyxoma peritonei$181,333
R21 · FY2021 · CA · contact PI
Application of Mucolytic Therapy in Patient-Derived Models of Pseudomyxoma Peritonei$204,233
R21 · FY2020 · CA · contact PI
Application of Mucolytic Therapy in Patient-Derived Models of Pseudomyxoma Peritonei$170,194
R21 · FY2019 · CA · contact PI